Peter Blake

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...

Mr. Corte has acted on a number of complex and/or contested takeover assignments and trans-Atlantic transactions, including:Adevinta ASA in its announced US$9.2 billion acquisition of eBay Classifieds Group from eBay Inc.;Intel Corporation’s US$15.3 billion acquisition of Mobileye N.V.;Konecranes’ proposed all-stock merger with Terex Corporation (NYSE) and its subsequent acquisition of a division of Terex;VimpelCom’s (now VEON) US$30 billion exchange offer for OJSC VimpelCom...

Mr. Macaulay has been recommended as a leading individual for over a decade in both Chambers UK and The Legal 500 UK. He has been described in these publications as an “unflappable” lawyer who “has extremely good judgement and is a ruthless tactician;” and is “rock solid;” “tenacious;” “a financial disputes expert;” and a “seasoned litigator.” He was included in Who’s Who Legal: Arbitration 2021’s annual Globa...

Mr. Anderson is highly experienced in private capital arrangements, with a particular focus on the establishment and ongoing operations of asset management structures; portfolio investments in liquid markets, infrastructure, real estate and technology; and compensation for fund principals.

Sunay Radia focuses his practice on financial restructuring transactions, including high yield bond and LBO workouts, refinancings, consensual and nonconsensual restructurings, enforcements and distressed asset sales. He has advised on a number of complex cross border matters for creditors (including direct lenders and distressed debt funds) and sponsors. Sunay also has a wealth of experience in origination banking and finance matters, including acquisition finance and real estate finance tra...

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devi...

Rob Day is a partner in Proskauer’s Corporate Department and a member of our Private Equity Transactions, Mergers & Acquisitions and Sports Groups. Rob’s practice focuses on public and private M&A, leveraged buyouts and joint ventures, private equity and portfolio company transactions. His clients include global corporations, asset managers and private equity houses, advising on their strategically important transactions across financial services, consumer, sports, media a...

Franz Schwarz focuses on complex multi-jurisdictional disputes. He has extensive experience with arbitral practice, procedure and advocacy both in civil and common law systems. Mr. Schwarz has been involved in more than 250 arbitrations as counsel and arbitrator, both ad-hoc and before all major arbitral institutions (including ICC, LCIA, Vienna and Stockholm), at multiple seats and governed by a broad variety of substantive and procedural laws. He has a particular focus on joint venture, M&a...

The leader of Pillsbury’s Data Privacy & Cybersecurity practice in Europe and global Marketing Law team, Rafi has been highly ranked by Chambers and Legal 500 for 20+ years for e-commerce, data and marketing law (including as Tier 1 and Hall of Fame). Rafi is chair of the Ad Law Group. He is also listed in Who’s Who Data. Rafi advises clients, from the world’s largest companies to startups, on entry to new markets, marketing and launch of new technology/products and EU a...

Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences grou...